Kalif Eliyahu Sharon Insider Trades & Stock Holdings

EVP, Chief Financial Officer · Teva Pharmaceutical Industries Limited · Latest filing Jun 11, 2026

Kalif Eliyahu Sharon, EVP, Chief Financial Officer at Teva Pharmaceutical Industries Limited has 1 Form 4 trade on file since Jun 11, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($3.63M), net -$3.63M. Latest filing: disposed of 106.56K shares of $TEVA on Jun 11, 2026 at $34.10.

Trades on file

1

Open-market bought

$0

Open-market sold

$3.63M

Net open-market

-$3.63M

Latest filing

Jun 11, 2026

All insider trades by Kalif Eliyahu Sharon

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 11, 2026	$TEVA	Sell (Open-market sale) 10b5-1	106.56K	$34.10	$3.63M			-8.9%	-6.9%		EVP, Chief Financial Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Kalif Eliyahu Sharon traded

• $TEVA

Frequently asked questions

Has Kalif Eliyahu Sharon been buying or selling stock?

Kalif Eliyahu Sharon has 0 open-market purchases and 1 open-market sale on file, net -$3.63M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Kalif Eliyahu Sharon's latest insider trade?

disposed of 106.56K shares of $TEVA on Jun 11, 2026 at $34.10.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.